Tokyo Tape
Sign in
← Otsuka Holdings

Quarterly report · Q3

4578.TEDINET S100PGE4
Period2022-01-01 → 2022-09-30
Filed2022-11-02
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥1.27T2022-01-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥451.8bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥1.50T2021-01-01 → 2021-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.11T2021-01-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥388.6bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥114.8bn2022-01-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥47.7bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥158.1bn2021-01-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥47.0bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥146.0bn2022-01-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥53.2bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥163.6bn2021-01-01 → 2021-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥166.3bn2021-01-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥47.1bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥111.0bn2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥41.3bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥125.5bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥126.6bn2021-01-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥35.2bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥113.9bn2022-01-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥42.4bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥130.0bn2021-01-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥36.3bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥3.19Tat 2022-09-30Cons.Assets IFRS
Total assets¥2.82Tat 2021-12-31Cons.Assets IFRS
Total assets¥2.82Tat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥853.3bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥775.7bnat 2021-12-31Cons.Liabilities IFRS
Net assets / equity¥2.33Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥2.05Tat 2021-12-31Cons.Equity IFRS
Net assets / equity¥2.02Tat 2021-09-30Cons.Equity IFRS
Net assets / equity¥1.88Tat 2020-12-31dCons.Equity IFRS
Equity (owners)¥2.30Tat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.01Tat 2021-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.98Tat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥477.3bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥410.7bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥448.7bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥356.9bnat 2020-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥171.1bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥228.9bn2021-01-01 → 2021-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥197.2bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥60.4bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥95.3bn2021-01-01 → 2021-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥33.0bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥84.0bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥95.8bn2021-01-01 → 2021-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥83.7bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥204.652022-01-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥76.062022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥231.322021-01-01 → 2021-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥233.52021-01-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥64.972021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥204.632022-01-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥76.042022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥231.152021-01-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥233.342021-01-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥64.82021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio72.1%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.3%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio70.5%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 88
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-01-01 → 2022-09-30¥126.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-07-01 → 2022-09-30¥43.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-01-01 → 2022-09-30¥94.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-07-01 → 2022-09-30¥31.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-01-01 → 2022-09-30¥31.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-07-01 → 2022-09-30¥11.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-09-30¥9.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-07-01 → 2022-09-30¥2.0bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-09-30−¥32.0bn
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30−¥11.9bn
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-09-30−¥32.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-09-30−¥11.9bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-09-30−¥34.8bn
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥12.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2022-01-01 → 2022-09-30¥27.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2022-07-01 → 2022-09-30¥10.3bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2022-01-01 → 2022-09-30¥27.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2022-07-01 → 2022-09-30¥10.3bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2022-01-01 → 2022-09-30¥18m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥12m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2022-01-01 → 2022-09-30¥5.6bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2022-07-01 → 2022-09-30¥3.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2022-01-01 → 2022-09-30¥325.6bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2022-07-01 → 2022-09-30¥119.9bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2022-01-01 → 2022-09-30¥325.6bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2022-07-01 → 2022-09-30¥119.9bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2022-01-01 → 2022-09-30¥18m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥7m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2022-01-01 → 2022-09-30¥49.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2022-07-01 → 2022-09-30¥21.6bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2022-01-01 → 2022-09-30¥819.3bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2022-07-01 → 2022-09-30¥290.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2022-01-01 → 2022-09-30¥819.3bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2022-07-01 → 2022-09-30¥290.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-09-30¥84.5bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2022-07-01 → 2022-09-30¥32.3bn
—segment totalrevenue2022-01-01 → 2022-09-30¥1.30T
—segment totalrevenue2022-07-01 → 2022-09-30¥463.7bn
—segment totalrevenue external2022-01-01 → 2022-09-30¥1.27T
—segment totalrevenue external2022-07-01 → 2022-09-30¥451.8bn
—segment totalrevenue intersegment2022-01-01 → 2022-09-30¥32.0bn
—segment totalrevenue intersegment2022-07-01 → 2022-09-30¥11.9bn
—segment totalsegment profit2022-01-01 → 2022-09-30¥149.7bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥59.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-01-01 → 2021-09-30¥110.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-07-01 → 2021-09-30¥36.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-01-01 → 2021-09-30¥82.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-07-01 → 2021-09-30¥26.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-01-01 → 2021-09-30¥28.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-07-01 → 2021-09-30¥10.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-01-01 → 2021-09-30¥12.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-07-01 → 2021-09-30¥2.8bn
Reconciling Itemsreconcilingrevenue2021-01-01 → 2021-09-30−¥28.5bn
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-09-30−¥10.4bn
Reconciling Itemsreconcilingrevenue intersegment2021-01-01 → 2021-09-30−¥28.5bn
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-09-30−¥10.4bn
Reconciling Itemsreconcilingsegment profit2021-01-01 → 2021-09-30−¥33.6bn
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-09-30−¥11.8bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2021-01-01 → 2021-09-30¥24.1bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2021-07-01 → 2021-09-30¥8.9bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2021-01-01 → 2021-09-30¥24.1bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2021-07-01 → 2021-09-30¥8.9bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2021-01-01 → 2021-09-30¥17m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥8m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2021-01-01 → 2021-09-30¥5.8bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2021-07-01 → 2021-09-30¥2.5bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2021-01-01 → 2021-09-30¥280.1bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2021-07-01 → 2021-09-30¥104.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2021-01-01 → 2021-09-30¥280.0bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2021-07-01 → 2021-09-30¥104.7bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2021-01-01 → 2021-09-30¥33m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥12m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2021-01-01 → 2021-09-30¥45.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2021-07-01 → 2021-09-30¥19.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2021-01-01 → 2021-09-30¥721.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2021-07-01 → 2021-09-30¥248.5bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2021-01-01 → 2021-09-30¥721.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2021-07-01 → 2021-09-30¥248.5bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2021-01-01 → 2021-09-30¥128.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2021-07-01 → 2021-09-30¥34.5bn
—segment totalrevenue2021-01-01 → 2021-09-30¥1.14T
—segment totalrevenue2021-07-01 → 2021-09-30¥399.0bn
—segment totalrevenue external2021-01-01 → 2021-09-30¥1.11T
—segment totalrevenue external2021-07-01 → 2021-09-30¥388.6bn
—segment totalrevenue intersegment2021-01-01 → 2021-09-30¥28.5bn
—segment totalrevenue intersegment2021-07-01 → 2021-09-30¥10.4bn
—segment totalsegment profit2021-01-01 → 2021-09-30¥191.8bn
—segment totalsegment profit2021-07-01 → 2021-09-30¥58.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 835
ItemContextValueUnit
Profit loss attributable to owners of parent IFRSCurrentYTDDuration111030000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration3384000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration2914000000JPY
Profit loss IFRSPrior1YTDDuration130033000000JPY
Profit loss IFRSCurrentYTDDuration113945000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration233.50
Basic earnings loss per share IFRSCurrentYTDDuration204.65
Diluted earnings loss per share IFRSPrior1YTDDuration233.34
Diluted earnings loss per share IFRSCurrentYTDDuration204.63
Revenue IFRSPrior1QuarterDuration388602000000JPY
Revenue IFRSCurrentQuarterDuration451811000000JPY
Cost of sales IFRSPrior1QuarterDuration123460000000JPY
Cost of sales IFRSCurrentQuarterDuration152728000000JPY
Gross profit IFRSPrior1QuarterDuration265141000000JPY
Gross profit IFRSCurrentQuarterDuration299083000000JPY
Selling general and administrative expenses IFRSPrior1QuarterDuration155956000000JPY
Selling general and administrative expenses IFRSCurrentQuarterDuration183933000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1QuarterDuration2008000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentQuarterDuration975000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1QuarterDuration59601000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentQuarterDuration68557000000JPY
Impairment losses pl IFRSPrior1QuarterDuration4741000000JPY
Impairment losses pl IFRSCurrentQuarterDuration6340000000JPY
Other income IFRSPrior1QuarterDuration1868000000JPY
Other income IFRSCurrentQuarterDuration6922000000JPY
Other expenses IFRSPrior1QuarterDuration1756000000JPY
Other expenses IFRSCurrentQuarterDuration447000000JPY
Operating profit loss IFRSPrior1QuarterDuration46961000000JPY
Operating profit loss IFRSCurrentQuarterDuration47701000000JPY
Finance income IFRSPrior1QuarterDuration916000000JPY
Finance income IFRSCurrentQuarterDuration7023000000JPY
Finance costs IFRSPrior1QuarterDuration777000000JPY
Finance costs IFRSCurrentQuarterDuration1514000000JPY
Profit loss before tax IFRSPrior1QuarterDuration47100000000JPY
Profit loss before tax IFRSCurrentQuarterDuration53210000000JPY
Income tax expense IFRSPrior1QuarterDuration10768000000JPY
Income tax expense IFRSCurrentQuarterDuration10772000000JPY
Profit loss IFRSPrior1QuarterDuration36332000000JPY
Profit loss IFRSCurrentQuarterDuration42437000000JPY
Profit loss attributable to owners of parent IFRSPrior1QuarterDuration35240000000JPY
Profit loss attributable to owners of parent IFRSCurrentQuarterDuration41276000000JPY
Profit loss attributable to non controlling interests IFRSPrior1QuarterDuration1092000000JPY
Profit loss attributable to non controlling interests IFRSCurrentQuarterDuration1160000000JPY
Profit loss IFRSPrior1QuarterDuration36332000000JPY
Profit loss IFRSCurrentQuarterDuration42437000000JPY
Basic earnings loss per share IFRSPrior1QuarterDuration64.97
Basic earnings loss per share IFRSCurrentQuarterDuration76.06
Diluted earnings loss per share IFRSPrior1QuarterDuration64.80
Diluted earnings loss per share IFRSCurrentQuarterDuration76.04
Profit loss IFRSPrior1YTDDuration130033000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2021-12-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass